Excluding primary hepatocellular carcinoma, determination of prothrombin time and measurement of PIVKA levels (especially PIVKA‐II, or degamma‐carboxylated prothrombin) can be used to assess the severity of vitamin K deficiency [19, 20]. This evidence concerns the gene F2 and hepatocellular carcinoma.